SCHEMBL17023571

SCHEMBL17023571

COc1cccc(-c2c(C)cccc2C=O)c1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.49
TLR2 O60603 1/20 0.49
TLR1 Q15399 1/20 0.49
TLR6 Q9Y2C9 1/20 0.49
SRC P12931 1/20 0.42
ALDH1A1 P00352 6/20 0.42
TSHR P16473 3/20 0.42
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
LMNA P02545 2/20 0.40
MAPK3 P27361 2/20 0.39
MAPK1 P28482 2/20 0.39
MAP2K1 Q02750 2/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 2/20 0.39
MEN1 O00255 1/20 0.39
GMNN O75496 1/20 0.39
RAF1 P04049 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15608279 0.85 AR (0.48) ERN1TLR2TLR1TLR6SRC
SCHEMBL15618978 0.83 ERN1 (0.53) ERN1TLR2TLR1TLR6SRC
SCHEMBL30203863 0.82 ERN1 (0.56) ERN1TLR2TLR1TLR6SRC
SCHEMBL19608992 0.82 ERN1 (0.56) ERN1TLR2TLR1TLR6SRC
SCHEMBL19608967 0.81 ERN1 (0.51) ERN1TLR2TLR1TLR6SRC
SCHEMBL1043732 0.80 ERN1 (0.61) ERN1TLR2TLR1TLR6SRC
SCHEMBL15619375 0.78 ALDH1A1 (0.44) ERN1ALDH1A1TSHRCYP1A2CYP2C19
SCHEMBL17023603 0.78 ALDH1A1 (0.44) ERN1ALDH1A1TSHRCYP1A2CYP2C19
SCHEMBL16778000 0.77 ALDH1A1 (0.43) ALDH1A1TSHRCYP1A2CYP2C19LMNA
SCHEMBL1666430 0.77 ALDH1A1 (0.59) ERN1TLR2TLR1TLR6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897947-B1 ALKYL, FLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2016-10-26 EP disclosed
US-9242941-B2 Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2016-01-26 US disclosed
US-20150239851-A1 ALKYL, FLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS BRISTOL-METERS SQUIBB COMPANY (US) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239851-A1 ALKYL, FLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS CNR1, CNR2, NR1I3 ERN1 3115/4885TLR2 3518/4885TLR1 3374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.